Navigation Links
Express Scripts Strives to Make Prescription Drugs Affordable and Accessible to American Families
Date:6/21/2011

ons of members realize greater healthcare outcomes and lowering cost by assisting in influencing their behavior. Headquartered in St. Louis, Express Scripts provides integrated PBM services including network-pharmacy claims processing, home delivery services, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. More information can be found at http://www.express-scripts.com/ and http://www.consumerology.com/.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements, including, but not limited to, statements related to the Company's plans, objectives, expectations (financial and otherwise) or intentions. Actual events may differ significantly from those projected or suggested in any forward-looking statements. Factors that may impact these forward-looking statements can be found in "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form 10-K filed with the SEC on February 16, 2011 and in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's Form 10-Q filed with the SEC on April 25, 2011. A copy of these forms can be found at the Investor Relations section of Express Scripts' web site at http://www.express-scripts.com.

The Company does not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Media contact: Thom Gross
314.684.6321 or 314.922.6226

SOURCE Express Scripts, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ALS TDI Completes Gene Expression Profile of Lou Gehrigs Disease in Mice
2. BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types
3. BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data
4. TAXUS(R) Express(TM) Stent Shows Similarly Low Re-intervention Rates in Diabetic Patients Compared to Non-Diabetics in ARRIVE 1 and 2 registries
5. SPIRIT III Results Reaffirm Strong Performance of Boston Scientific PROMUS(TM) and TAXUS(R) Express(R) Stents
6. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
7. Genomic Health Announces Data Supporting Use of Oncotype DX(R) to Accurately Assess HER2 Gene Expression in Breast Cancer Patients
8. International Medical Corps Matched with Top 25 American Express Members Project, Saving the Lives of Malnourished Children
9. TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program
10. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)...  Neuraltus Pharmaceuticals, Inc. announced today that promising efficacy ... NP001 for the treatment of amyotrophic lateral sclerosis (ALS, ... today in an oral presentation at the inaugural ... in Bloomington, Minnesota , September 17-19, ... a high dose of NP001 (2mg/kg) was associated with ...
(Date:9/17/2014)... , Sept. 17 2014 IBM (NYSE: ... is using IBM technical computing and storage technology ... cancer patients. These services deliver critically important information ... each patient,s unique cancer, which could lead to ... healthcare system in general. Today, optimal ...
(Date:9/17/2014)... Switzerland , September 17, 2014 /PRNewswire/ ... , is proud to congratulate Biocartis commitment in ... Diagnostics is a long-time investor in Biocartis as ... ™ Biocartis, fully automated, real-time PCR based ... fast and easy access to clinical molecular diagnostic ...
Breaking Medicine Technology:Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 2Neuraltus Pharmaceuticals' ALS Treatment Candidate, NP001, Highlighted at ALS Research Group Summit 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 2Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 3Caris Life Sciences Selects IBM to Accelerate Use of Molecular Profiling in Cancer Treatment Selection 4Debiopharm Diagnostics Portfolio Company Biocartis Ships its First Idylla Instrument 2
... N.J. , March 11 Bayer HealthCare ... been granted by the U.S. Food and Drug Administration ... of pulmonary infection due to Pseudomonas aeruginosa in cystic ... granted by the European Medicines Agency. Ciprofloxacin DPI is ...
... DETROIT , March 11 Caraco Pharmaceutical ... oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, which ... from the US Food and Drug Administration (FDA) for ... an anticancer used in the treatment of colon and ...
Cached Medicine Technology:FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 2FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 3FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 4FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 5FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 6FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 7FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3
(Date:9/17/2014)... September 17, 2014 Kristen Yarker, MSc, RD ... parents of children 9 months to 2 years old who ... furthermore, prevent picky eaters from developing by encouraging healthy eating ... (9 months to 2 years): How to Transition From Baby ... Is Getting the Nutrition They Need)” is a new online ...
(Date:9/17/2014)... Diego, Calif. (PRWEB) September 17, 2014 ... Nature’s monthly interruptions, giving girls of all ages ... a wellness company founded by women, for women, ... Girl Uninterrupted® (http://GirlU.com) to relieve the ... cramps, bloating and irritability. , As a ...
(Date:9/17/2014)... A raucous childhood in an Italian-Polish ... form author Nancy Chovancek’s laughter-filled new book, “Angry Birds ... of short stories that prove the best way to ... positive message of empowerment and resilience, everyone can identify ... author with two books under her belt on the ...
(Date:9/17/2014)... Seattle, Wa (PRWEB) September 17, 2014 ... published by the Telegraph in August 2014, scientists made ... cure for diabetes, but still failed. The article indicates ... , Despite this existing fact, there are many forward-thinking ... for diabetes treatment in a natural way. Dr. Kenneth ...
(Date:9/17/2014)... In honor of National Health IT Week Sept. ... professionals for gaining a competitive edge in the healthcare ... demand for qualified health IT professionals are at an ... differentiating factor when filling a position. The skill most ... clinical workflow and terminology experience. American Sentinel offers ...
Breaking Medicine News(10 mins):Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 2Health News:Nutritionist Kristen Yarker Offers Parents a Fresh Approach to Prevent Picky Eaters in New Online Seminar 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 2Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 3Health News:Girl Uninterrupted® Debuts New Look for All-Natural, PMS-Relief Supplement, Launching Today 4Health News:Discover a Safe and Effective Treatment for Diabetes with The Diabetes Protocol – Vinamy 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 2Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 3Health News:American Sentinel University Offers Tips to Health IT Professionals for Gaining Competitive Edge in the Job Market 4
... A protein abundantly found in treatment-resistant cancers holds an ... would normally detect DNA damage and force defective cells ... the current Cancer Cell . "Overexpression ... resistance to DNA-damaging chemotherapy, but we haven,t known how ...
... , SUNDAY, Feb. 26 (HealthDay News) -- Researchers report that ... mature into eggs that may be capable of fertilization. ... potentially lead to new reproductive technologies and possibly extend the ... that women were born with a lifetime supply of eggs, ...
... (HealthDay News) -- A potentially dangerous heart rhythm problem called ... decline in older people at risk for heart disease, new ... the Canadian Medical Association Journal , researchers analyzed data ... countries, aged 55 and older. All of the participants had ...
... lives and may save money. There are two very commonly ... it is unclear which is the most effective and provides ... BY-BAND study led by the University of Bristol and funded ... (NIHR HTA) programme will compare the outcomes of stomach bypass ...
... a new treatment for type 2 diabetes, improves blood sugar ... significantly lower risk of creating a dangerous drop in blood ... results of the phase 2 randomized trial were published Online ... diabetes is the most common form of diabetes accounting for ...
... An experimental drug improves patients, blood sugar control without ... with type 2 diabetes, according to the results of a ... more prevalent form of the disease, accounting for about 90 ... diabetes involves a gradual decline in how insulin responds to ...
Cached Medicine News:Health News:Aurora-A hinders tumor-suppressor to allow chemotherapy resistance 2Health News:Aurora-A hinders tumor-suppressor to allow chemotherapy resistance 3Health News:Stem Cell Finding Could Expand Women's Lifetime Supply of Eggs 2Health News:Stem Cell Finding Could Expand Women's Lifetime Supply of Eggs 3Health News:Irregular Heartbeat May Predict Mental Decline in Some 2Health News:Which type of obesity surgery is best? 2Health News:Diabetes drug gets patients with Type 2 diabetes on target 2Health News:Experimental Drug Shows Promise Against Type 2 Diabetes 2Health News:Experimental Drug Shows Promise Against Type 2 Diabetes 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: